330 Combination therapy with stem cell derived natural killer cells and monoclonal antibodies leads to potent ADCC through engagement of endogenouse CD16
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
2023-11-01
|
| Colección: | Journal for ImmunoTherapy of Cancer |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|